NMR in target driven drug discovery: why not?

Sébastien Keiffer; Marta G. Carneiro; Johan G. Hollander; Masakazu Kobayashi; Denys Pogoryelev; Eiso AB; Stephan Theisgen; Gerhard Müller; Gregg Siegal

doi:10.1007/s10858-020-00343-9

JOURNAL ARTICLE

NMR in target driven drug discovery: why not?

Sébastien Keiffer Marta G. Carneiro Johan G. Hollander Masakazu Kobayashi Denys Pogoryelev Eiso AB Stephan Theisgen Gerhard Müller Gregg Siegal

Year: 2020 Journal: Journal of Biomolecular NMR Vol: 74 (10-11)Pages: 521-529 Publisher: Springer Science+Business Media

DOI: 10.1007/s10858-020-00343-9

Get Full-Text PDF Get Analytical Report

Keywords:

Drug discovery Computational biology Chemistry Strengths and weaknesses Small molecule Data science Drug target Biochemical engineering Computer science Nanotechnology Combinatorial chemistry Biochemistry Biology Psychology

Metrics

Cited By

1.77

FWCI (Field Weighted Citation Impact)

Refs

0.88

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Computational Drug Discovery Methods

Physical Sciences → Computer Science → Computational Theory and Mathematics

Protein Structure and Dynamics

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

ATP Synthase and ATPases Research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

NMR in target driven drug discovery: why not?

Metrics

Citation History

Topics

Related Documents

Target-Driven Drug Discovery

Target-Driven Drug Discovery

Target Mutation-Driven Drug Discovery

Organoid-Driven Drug Discovery: Precision Screening and Target Validation

Omics-driven Approaches in Biomarker and Drug Target Discovery